4M THERAPEUTICS INC.
4MTx is developing small molecules to treat neuropsychiatric disorders by enhancing neuroplasticity and reducing neuro-inflammation.
4M THERAPEUTICS INC.
Social Links:
Website Url:
http://www.4mtx.net
Status:
Active
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default Google Font API LetsEncrypt Content Delivery Network Euro Google Apps For Business Typekit LocalBusiness Schema
Current Employees Featured
Founder
Official Site Inspections
http://www.4mtx.net Semrush global rank: 8.64 M Semrush visits lastest month: 274
- Host name: 198.185.159.145
- IP address: 198.185.159.145
- Location: New York United States
- Latitude: 40.7157
- Longitude: -74
- Metro Code: 501
- Timezone: America/New_York
- Postal: 10013
More informations about "4M Therapeutics Inc."
4M Therapeutics Inc. - Crunchbase Company Profile & Funding
4M Therapeutics Inc. (4MTx) develops therapies for central nervous system (CNS) disorders with blockbuster potential. We focus on targets implicated in a wide array of disorders and …See details»
4M Therapeutics Inc. - LinkedIn
4M Therapeutics Inc. (4MTx) is developing targeted therapies for central nervous system (CNS) disorders. Our discovery platform was developed at Harvard, MIT and the University of Washington to ...See details»
4M Therapeutics Awarded $120,000 Grant from SynGAP Research …
Skillman, NJ – Nov. 12, 2024 – 4M Therapeutics Inc. (4MTx), an early-stage biotechnology company developing treatments for neuropsychiatric and neurodegenerative diseases, today …See details»
4M Therapeutics Company Profile 2024: Valuation, Funding
4M Therapeutics General Information Description. Operator of a biotech company intended to develop a pipeline of small molecules by studying their effects on brain cells derived from …See details»
4M Therapeutics’ Compounds to be Utilized in Research
Oct 17, 2024 4M Therapeutics Inc. (4MTx) is advancing treatments for neuropsychiatric and neurodegenerative diseases. The Company focuses on targets for a wide array of disorders …See details»
4M Therapeutics Strengthens Executive Leadership Team
Mar 4, 2024 4M Therapeutics Inc. (4MTx) is advancing treatments for neuropsychiatric and neurodegenerative conditions. ... For more information, visit www.4mtx.net. Contacts. For …See details»
4M Therapeutics, Inc. - Drug pipelines, Patents, Clinical trials
For more information, visit www.4mtx.net . 13 May 2024 ... The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is …See details»
4M Therapeutics Announces Formation of Clinical Advisory Board …
May 2, 2024 4M Therapeutics Inc. (4MTx) is advancing treatments for neuropsychiatric and neurodegenerative diseases. ... For more information, visit www.4mtx.net. View source version …See details»
4M Therapeutics’ Compounds to Be Utilized in Research Project …
Oct 17, 2024 4M Therapeutics Inc. (4MTx) is advancing treatments for neuropsychiatric and neurodegenerative diseases. ... For more information, visit www.4mtx.net. Contacts. For …See details»
4MT2001 - Drug Targets, Indications, Patents - Synapse
Originator Organization. 4M Therapeutics, Inc. Active Organization. 4M Therapeutics, Inc. Inactive Organization-Drug Highest ... mania, agitation in Alzheimer’s disease, neurodegeneration, and …See details»
4M Therapeutics Strengthens Executive Leadership Team with …
Mar 4, 2024 Dr. Lee brings over 20 years of biotechnology industry and Wall Street experience. Skillman, NJ – March 4, 2024 – 4M Therapeutics Inc., an early-stage biotechnology company …See details»
4M Therapeutics Presented Novel Preclinical Data at SOBP Annual …
May 13, 2024 About 4M Therapeutics Inc. 4M Therapeutics Inc. (4MTx) is advancing treatments for neuropsychiatric and neurodegenerative conditions. The Company focuses on targets for a …See details»
4M Therapeutics’ Compounds to Be Utilized in Research Project …
Oct 17, 2024 About 4M Therapeutics Inc. 4M Therapeutics Inc. (4MTx) is advancing treatments for neuropsychiatric and neurodegenerative diseases. The Company focuses on targets for a …See details»
4M Therapeutics joins MIT Startup Exchange — 4M Therapeutics
Feb 9, 2022 4M Therapeutics Inc. (4MTx) is a startup biotech company based on the belief that the study of human brain cells represents an important advance in neuroscience discovery. …See details»
4M Therapeutics Announces Positive Preclinical Data for Lead …
Sep 9, 2024 4M Therapeutics Inc. (4MTx), an early-stage biotechnology company developing treatments for neuropsychiatric and neurodegenerative diseases, today announced new …See details»
4M Therapeutics Announces Positive Preclinical Data for Lead …
SKILLMAN, N.J., September 09, 2024--(BUSINESS WIRE)--4M Therapeutics Inc. (4MTx), an early-stage biotechnology company developing treatments for neuropsychiatric and …See details»
4M Therapeutics Presented Novel Preclinical Data at SOBP Annual …
May 13, 2024 4M Therapeutics Inc. (4MTx) is advancing treatments for neuropsychiatric and neurodegenerative conditions. The Company focuses on targets for a wide array of disorders …See details»
4M Therapeutics Announces Positive Preclinical Data for Lead …
Sep 9, 2024 4M Therapeutics Inc. (4MTx) is advancing treatments for neuropsychiatric and neurodegenerative diseases. The Company focuses on targets for a wide array of disorders …See details»
4M Therapeutics, Inc., Enters Into Strategic Partnership with Vala ...
Jul 29, 2022 About 4MTx: 4M Therapeutics Inc. is a startup biotech company based on the principle that the study of human brain cells represents an important advance in neuroscience …See details»